France· FR:63980742
ERIBULINE EVER PHARMA 0,44 mg/mL, solution injectable
A eribulin product containing mésilate d'éribuline, registered in France by EVER VALINJECT (AUTRICHE). The same ATC class is registered in 18 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Eribulin is registered in 18 of 19 countries.
Countries holding a registration under ATC L01XX41 (eribulin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Eribulin · ATC L01XX41
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉSILATE D'ÉRIBULINE
- Manufacturer
- EVER VALINJECT (AUTRICHE)
- Country
- France (FR)
- ATC code
- L01XX41
- ATC class
- Eribulin
- Defined daily dose
- 0.21 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009302932631 flacon en verre de 2 mL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
428 interactions on record for eribulin.
Graded by severity as the source publishes them — 93 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eribulin · interactions on record
428 records
- 93 severe
- 331 moderate
- 4 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eribulin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEribuline Baxter 0,44 mg/ml oplossing voor injectieBaxter Holding B.V.
- CzechiaERHOPANAAGmed s.r.o., Ostrava
- United Stateseribulin mesylateApotex Corp.
- SpainERIBULINA ADVANZ PHARMA 0,44 MG/ML SOLUCIÓN INYECTABLE EFGAdvanz Pharma Limited
- SwedenEribulin Accord 0,44 mg/ml Injektionsvätska, lösningAccord Healthcare B.V.
- FinlandEribulin AccordAccord Healthcare B.V.
- United KingdomEribulin 880micrograms/2ml solution for injection vialsDr Reddy's Laboratories (UK) Ltd
- BelgiumEribulin Advanz Pharma 0.44 mg/mlAdvanz Pharma
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Eribulin Accord, Eribulin Advanz Pharma
- Belgium · Eribulin Advanz Pharma, Eribulin Eg
- Bulgaria · Eribulin Ever Pharma, Sclarint
- Czechia · Erhopana, Eribulin Accord
- Germany · Eribulin Aqvida, Eribulin Beta
- Denmark · Eribulin Accord, Eribulin Ever Pharma
- Estonia · Eribulin, Eribulin Accord
- Spain · Eribulina, Eribulina Advanz Pharma
- Finland · Eribulin, Eribulin Accord
- United Kingdom (Northern Ireland) · Eribulin Dr. Reddy's Laboratories (Uk), Eribulin Glenmark Pharmaceuticals Europe
- Greece · Eribulin Ever Pharma
- Croatia · Eribulin, Eribulin Accord
- Hungary · Eribulin Advz, Eribulin Ever Pharma
- Ireland · Eribulin Advanz Pharma, Eribulin Ever Pharma
- Iceland · Advz, Eribulin Advanz Pharma
- Italy · Eribulina Advanz Pharma, Eribulina Eg
- Liechtenstein · Eribulin Baxter, Halaven
- Lithuania · Eribulin, Eribulin Accord
- Luxembourg · Eribulin Eg
- Latvia · Eribulin, Eribulin Advz
- Malta · Eribulin Tillomed
- Netherlands · Eribulin Ever Pharma, Eribuline Hikma
- Norway · Eribulin Accord, Eribulin Advanz Pharma
- Poland · Eribulin Ever Pharma
- Portugal · Eribulina Advanz Pharma, Eribulina Cttq
- Romania · Erhopana, Eribulin Ever Pharma
- Sweden · Eribulin, Eribulin Accord
- Slovenia · Eribulin Ever Pharma
- Slovakia · Eribulin Advz, Eribulin Agmed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6b3d4e8-67b8-43ff-97ea-29c0d98742ab GET /v1/drugs/b6b3d4e8-67b8-43ff-97ea-29c0d98742ab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63980742",
"date_amm": "2024-04-05",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "MÉSILATE D'ÉRIBULINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about eribulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.